{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:54:36Z","timestamp":1785887676318,"version":"3.56.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:00:00Z","timestamp":1785888000000},"content-version":"vor","delay-in-days":68,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Epidemiol Glob Health"],"DOI":"10.1007\/s44197-026-00537-8","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T05:13:43Z","timestamp":1780031623000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Global Epidemiology of Paroxysmal Nocturnal Hemoglobinuria: A Systematic Literature Review"],"prefix":"10.1007","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0009-0001-5809-1369","authenticated-orcid":false,"given":"Olessia","family":"Zorina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3632-2365","authenticated-orcid":false,"given":"Omid","family":"Beiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0685-1543","authenticated-orcid":false,"given":"Matthew","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jocelyn","family":"Buisker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Ferber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5042-5785","authenticated-orcid":false,"given":"Jilles M.","family":"Fermont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3318-9482","authenticated-orcid":false,"given":"Richard J.","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"537_CR1","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2017.28","author":"A Hill","year":"2017","unstructured":"Hill A, Dezern AE, Kinoshita T, Brodsky RA. Paroxysmal nocturnal haemoglobinuria. Nat Rev Dis Primers. 2017. https:\/\/doi.org\/10.1038\/nrdp.2017.28.","journal-title":"Nat Rev Dis Primers"},{"issue":"3","key":"537_CR2","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1016\/j.htct.2020.06.006","volume":"43","author":"RD Cancado","year":"2021","unstructured":"Cancado RD, Araujo ADS, Sandes AF, Arrais C, Lobo CLC, Figueiredo MS. Consensus statement for diagnosis and treatment of paroxysmal nocturnal haemoglobinuria. Hematol Transfus Cell Ther. 2021;43(3):341\u20138.","journal-title":"Hematol Transfus Cell Ther"},{"issue":"12","key":"537_CR3","doi-asserted-by":"publisher","first-page":"3699","DOI":"10.1182\/blood-2005-04-1717","volume":"106","author":"C Parker","year":"2005","unstructured":"Parker C, Omine M, Richards S, Nishimura J, Bessler M, Ware R. Diagnosis and management of paroxysmal nocturnal hemoglobinuria. Blood. 2005;106(12):3699\u2013709.","journal-title":"Blood"},{"issue":"6","key":"537_CR4","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1007\/s12185-016-1995-1","volume":"103","author":"F Yu","year":"2016","unstructured":"Yu F, Du Y, Han B. A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe\/America. Int J Hematol. 2016;103(6):649\u201354.","journal-title":"Int J Hematol"},{"issue":"8","key":"537_CR5","doi-asserted-by":"publisher","first-page":"3099","DOI":"10.1182\/blood-2008-01-133918","volume":"112","author":"RP de Latour","year":"2008","unstructured":"de Latour RP, Mary JY, Salanoubat C, Terriou L, Etienne G, Mohty M, et al. Paroxysmal nocturnal hemoglobinuria: natural history of disease subcategories. Blood. 2008;112(8):3099\u2013106.","journal-title":"Blood"},{"issue":"9","key":"537_CR6","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/imj.13160","volume":"46","author":"G Soci\u00e9","year":"2016","unstructured":"Soci\u00e9 G, Schrezenmeier H, Muus P, Lisukov I, R\u00f6th A, Kulasekararaj A, et al. Changing prognosis in paroxysmal nocturnal haemoglobinuria disease subcategories: an analysis of the International PNH Registry. Intern Med J. 2016;46(9):1044\u201353.","journal-title":"Intern Med J"},{"issue":"1","key":"537_CR7","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000369773","volume":"134","author":"M Ge","year":"2015","unstructured":"Ge M, Shi J, Li X, Shao Y, Huang J, Huang Z, et al. Clinical features and survival of asian pediatric patients with paroxysmal nocturnal hemoglobinuria: results from a single center in China. Acta Haematol. 2015;134(1):1\u20136.","journal-title":"Acta Haematol"},{"issue":"3","key":"537_CR8","doi-asserted-by":"publisher","first-page":"e76","DOI":"10.3324\/haematol.2016.151852","volume":"102","author":"\u00c1 Urbano-Ispizua","year":"2017","unstructured":"Urbano-Ispizua \u00c1, Muus P, Schrezenmeier H, Almeida AM, Wilson A, Ware RE. Different clinical characteristics of paroxysmal nocturnal hemoglobinuria in pediatric and adult patients. Haematologica. 2017;102(3):e76\u20139.","journal-title":"Haematologica"},{"key":"537_CR9","first-page":"S8","volume":"26","author":"M Bektas","year":"2020","unstructured":"Bektas M, Copley-Merriman C, Khan S, Sarda SP, Shammo JM. Paroxysmal nocturnal hemoglobinuria: patient journey and burden of disease. J Manag Care Spec Pharm. 2020;26:S8-14.","journal-title":"J Manag Care Spec Pharm"},{"key":"537_CR10","unstructured":"Rare Disease Database [Internet]. 2024. Available from: https:\/\/rarediseases.org."},{"key":"537_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.blre.2023.101158","volume":"64","author":"A Waheed","year":"2024","unstructured":"Waheed A, Shammo J, Dingli D. Paroxysmal nocturnal hemoglobinuria: review of the patient experience and treatment landscape. Blood Rev. 2024;64:101158.","journal-title":"Blood Rev"},{"key":"537_CR12","unstructured":"Research Registry [Internet]. 2025. Available from: https:\/\/www.researchregistry.com\/"},{"issue":"10","key":"537_CR13","first-page":"2127","volume":"18","author":"Z Munn","year":"2020","unstructured":"Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020;18(10):2127\u201333.","journal-title":"JBI Evid Synth"},{"key":"537_CR14","doi-asserted-by":"publisher","first-page":"n71","DOI":"10.1136\/bmj.n71","volume":"372","author":"MJ Page","year":"2021","unstructured":"Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.","journal-title":"BMJ"},{"issue":"2","key":"537_CR15","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1111\/ejh.13640","volume":"107","author":"SJ Richards","year":"2021","unstructured":"Richards SJ, Painter D, Dickinson AJ, Griffin M, Munir T, Arnold L, et al. The incidence and prevalence of patients with paroxysmal nocturnal haemoglobinuria and aplastic anaemia PNH syndrome: A retrospective analysis of the UK\u2019s population-based haematological malignancy research network 2004\u20132018. Eur J Haematol. 2021;107(2):211\u20138.","journal-title":"Eur J Haematol"},{"issue":"5","key":"537_CR16","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/cyto.b.21480","volume":"92","author":"M Morado","year":"2017","unstructured":"Morado M, Freire Sandes A, Colado E, Subir\u00e1 D, Isusi P, Soledad Noya M, et al. Diagnostic screening of paroxysmal nocturnal hemoglobinuria: prospective multicentric evaluation of the current medical indications. Cytometry Part B: Clinical Cytometry. 2017;92(5):361\u201370.","journal-title":"Cytometry Part B: Clinical Cytometry"},{"issue":"3","key":"537_CR17","doi-asserted-by":"publisher","first-page":"190","DOI":"10.5582\/irdr.2024.01016","volume":"13","author":"E Beleva","year":"2024","unstructured":"Beleva E. Epidemiological estimates of paroxysmal nocturnal hemoglobinuria in Bulgaria. Intractable Rare Dis Res. 2024;13(3):190\u20134.","journal-title":"Intractable Rare Dis Res"},{"issue":"1","key":"537_CR18","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1186\/s13023-024-03283-x","volume":"19","author":"J Spychalska","year":"2024","unstructured":"Spychalska J, Du\u0144ska M, My\u015bli\u0144ska A, Majewska-Wierzbicka M, Klimczak-Jajor E, G\u0142odkowska-Mr\u00f3wka E. Diagnostic landscape of first-time cytometric screening for paroxysmal nocturnal hemoglobinuria in Poland in 2013\u20132022. Orphanet J Rare Dis. 2024;19(1):271.","journal-title":"Orphanet J Rare Dis"},{"key":"537_CR19","doi-asserted-by":"publisher","DOI":"10.5001\/omj.2022.13","author":"AZ Al-Riyami","year":"2022","unstructured":"Al-Riyami AZ, Al-Kindi Y, Al-Qassabi J, Al-Mamari S, Fawaz N, Al-Khabori M, et al. Clinicopathological profile of paroxysmal nocturnal hemoglobinuria among Omani patients: a case series. Oman Med J. 2022. https:\/\/doi.org\/10.5001\/omj.2022.13.","journal-title":"Oman Med J"},{"issue":"1","key":"537_CR20","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/s13023-022-02290-0","volume":"17","author":"K Ninomiya","year":"2022","unstructured":"Ninomiya K, Okura M. Nationwide comprehensive epidemiological study of rare diseases in Japan using a health insurance claims database. Orphanet J Rare Dis. 2022;17(1):140.","journal-title":"Orphanet J Rare Dis"},{"issue":"7","key":"537_CR21","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1007\/s00277-020-04133-z","volume":"99","author":"KW Kang","year":"2020","unstructured":"Kang KW, Moon H, Lee BH, Jeon MJ, Yu ES, Kim DS, et al. Nationwide study of paroxysmal nocturnal hemoglobinuria in South Korea: paradox of eculizumab. Ann Hematol. 2020;99(7):1493\u2013503.","journal-title":"Ann Hematol"},{"issue":"6","key":"537_CR22","doi-asserted-by":"publisher","first-page":"930","DOI":"10.1111\/bjh.14888","volume":"182","author":"M Griffin","year":"2018","unstructured":"Griffin M, Neilly I, Nikolousis M, Narayanan S, Lowndes K, Koh M, et al. Lessons learned from a review of paroxysmal nocturnal haemoglobinuria (PNH) requests: a report from the UK PNH Network. Br J Haematol. 2018;182(6):930\u20133.","journal-title":"Br J Haematol"},{"issue":"8","key":"537_CR23","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.3346\/jkms.2024.39.e81","volume":"39","author":"JH Jang","year":"2024","unstructured":"Jang JH, Kim JS, Lim CTK, Kleinman NJ, Myren KJ, Wang A, et al. Impact of lactate dehydrogenase and hemoglobin levels on clinical outcomes in patients with paroxysmal nocturnal hemoglobinuria: results from the National Korean PNH Registry. J Korean Med Sci. 2024;39(8):e81.","journal-title":"J Korean Med Sci"},{"issue":"2","key":"537_CR24","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3346\/jkms.2016.31.2.214","volume":"31","author":"JH Jang","year":"2016","unstructured":"Jang JH, Kim JS, Yoon SS, Lee JH, Kim YK, Jo DY, et al. Predictive Factors of Mortality in Population of Patients with Paroxysmal Nocturnal Hemoglobinuria (PNH): Results from a Korean PNH Registry. J Korean Med Sci. 2016;31(2):214\u201321.","journal-title":"J Korean Med Sci"},{"issue":"11","key":"537_CR25","doi-asserted-by":"publisher","first-page":"a294","DOI":"10.1182\/blood.V108.11.985.985","volume":"108","author":"A Hill","year":"2006","unstructured":"Hill A, Platts PJ, Smith A, Richards SJ, Cullen MJ, Hill QA, et al. The incidence and prevalence of paroxysmal nocturnal hemoglobinuria (PNH) and survival of patients in Yorkshire. Blood. 2006;108(11):a294\u2013a.","journal-title":"Blood"},{"issue":"3","key":"537_CR26","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/ejh.14128","volume":"112","author":"C Rich","year":"2024","unstructured":"Rich C, Wilson K, Olsen J, Pedersen M, Frederiksen H. The disease burden of paroxysmal nocturnal hemoglobinuria in Denmark: Epidemiology, survival, healthcare resource utilization, costs, treatment gaps, and labor market attachment. Eur J Haematol. 2024;112(3):412\u201323.","journal-title":"Eur J Haematol"},{"issue":"7","key":"537_CR27","doi-asserted-by":"publisher","first-page":"e0288708","DOI":"10.1371\/journal.pone.0288708","volume":"18","author":"SF Menosi Gualandro","year":"2023","unstructured":"Menosi Gualandro SF, Salvino MA, Bassolli de Oliveira Alves L, Jeh\u00e1 T. Characteristics of paroxysmal nocturnal hemoglobinuria patients in Brazil: A retrospective administrative claims database analysis of PNH patients in Brazilian public healthcare system. PLoS One. 2023;18(7):e0288708.","journal-title":"PLoS One"},{"issue":"10","key":"537_CR28","volume":"15","author":"AL Sorensen","year":"2023","unstructured":"Sorensen AL, Lund Hansen D, Frederiksen H. Early mortality in paroxysmal nocturnal hemoglobinuria. Cureus. 2023;15(10):e47225.","journal-title":"Cureus"},{"key":"537_CR29","first-page":"109","volume":"2","author":"ES Korkama","year":"2018","unstructured":"Korkama ES, Overgaard U, Tj\u00f8nnfjord E, Vikman M, Ahmadi A, Pelliniemi TT, et al. The incidence of paroxysmal nocturnal hemoglobinuria cell clones in the nordic countries. HemaSphere. 2018;2:109\u201310.","journal-title":"HemaSphere"},{"issue":"6","key":"537_CR30","doi-asserted-by":"publisher","first-page":"e1006133","DOI":"10.1371\/journal.pcbi.1006133","volume":"14","author":"N Mon P\u00e8re","year":"2018","unstructured":"Mon P\u00e8re N, Lenaerts T, Pacheco JM, Dingli D. Evolutionary dynamics of paroxysmal nocturnal hemoglobinuria. PLoS Comput Biol. 2018;14(6):e1006133.","journal-title":"PLoS Comput Biol"},{"issue":"1","key":"537_CR31","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02725-2","volume":"18","author":"T Pichon","year":"2023","unstructured":"Pichon T, Messiaen C, Soussand L, Angin C, Sandrin A, Elarouci N, et al. Overview of patients\u2019 cohorts in the French National rare disease registry. Orphanet J Rare Dis. 2023;18(1):176.","journal-title":"Orphanet J Rare Dis"},{"key":"537_CR32","unstructured":"BNDMR The French. National Rare Disease Registry. 2024."},{"issue":"1","key":"537_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-023-02947-4","volume":"18","author":"F Pieroni","year":"2023","unstructured":"Pieroni F, Marrucci S, Di Pietro L, Berni C, Scaletti C. The Tuscany Regional Network for rare diseases: from European Reference Networks\u2019 experience to registry based organisation and management model for rare diseases. Orphanet J Rare Dis. 2023;18(1):324.","journal-title":"Orphanet J Rare Dis"},{"key":"537_CR34","unstructured":"Rete Toscana Malattie Rare [Internet]. 2024. Available from: https:\/\/malattierare.toscana.it\/rtmr-dati-statistici\/"},{"key":"537_CR35","unstructured":"Statistical report of rare disease confirmed cases in Taiwan [Internet]. Health Promotion Administration, Ministry of Health and Welfare. 2024. Available from: https:\/\/www.hpa.gov.tw\/EngPages\/List.aspx?nodeid=4115"},{"key":"537_CR36","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1182\/blood-2019-125867","volume":"134","author":"JJ Jalbert","year":"2019","unstructured":"Jalbert JJ, Chaudhari U, Zhang H, Weyne J, Shammo JM. Epidemiology of PNH and real-world treatment patterns following an incident PNH diagnosis in the US. Blood. 2019;134:3407.","journal-title":"Blood"},{"key":"537_CR37","doi-asserted-by":"publisher","first-page":"497","DOI":"10.2147\/CLEP.S250250","volume":"12","author":"DL Hansen","year":"2020","unstructured":"Hansen DL, M\u00f6ller S, Andersen K, Gaist D, Frederiksen H. Increasing incidence and prevalence of acquired hemolytic anemias in Denmark, 1980\u20132016. Clin Epidemiol. 2020;12:497\u2013508.","journal-title":"Clin Epidemiol"},{"issue":"1","key":"537_CR38","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-019-1032-6","volume":"14","author":"SS Lim","year":"2019","unstructured":"Lim SS, Lee W, Kim YK, Kim J, Park JH, Park BR, et al. The cumulative incidence and trends of rare diseases in South Korea: a nationwide study of the administrative data from the National Health Insurance Service database from 2011\u20132015. Orphanet J Rare Dis. 2019;14(1):49.","journal-title":"Orphanet J Rare Dis"},{"key":"537_CR39","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-024-03406-4","author":"A Worker","year":"2024","unstructured":"Worker A, Mahon H, Sams J, Boardman-Pretty F, Marchini E, Dubis R, et al. A machine learning algorithm for the detection of paroxysmal nocturnal haemoglobinuria (PNH) in UK primary care electronic health records. Orphanet J Rare Dis. 2024. https:\/\/doi.org\/10.1186\/s13023-024-03406-4.","journal-title":"Orphanet J Rare Dis"},{"key":"537_CR40","doi-asserted-by":"crossref","unstructured":"Tantravahi S, Latremouille-Viau D, Desai R, Lee S, Paulose J, Geevarghese A et al. EE452 Prevalence, Real-World Healthcare Resource Utilization, and Costs of Patients With Paroxysmal Nocturnal Hemoglobinuria in the US: A Retrospective Claims Database Analysis. 2024. p. S140.","DOI":"10.1016\/j.jval.2024.03.747"},{"issue":"2024(3)","key":"537_CR41","first-page":"43","volume":"3","author":"RA Zinchenko","year":"2024","unstructured":"Zinchenko RA, Tebieva IS, Gabisova YV, Shukan EY, Khokhova AV, Marakhonov AV, et al. Orphan diseases in the republic of North Ossetia\u2013Alania: structure, population genetic features, issues and prospects. Bull Russ State Med Univ. 2024;3(2024(3)):43\u201351.","journal-title":"Bull Russ State Med Univ"},{"key":"537_CR42","doi-asserted-by":"publisher","first-page":"1283","DOI":"10.1182\/blood-2023-188164","volume":"142","author":"J Croden","year":"2023","unstructured":"Croden J, Oliver M, Wu CM. Anticoagulation use and patient outcomes in paroxysmal nocturnal hemoglobinuria: a province-wide retrospective review. Blood. 2023;142:1283.","journal-title":"Blood"},{"issue":"3","key":"537_CR43","doi-asserted-by":"publisher","first-page":"96","DOI":"10.5582\/irdr.2022.01093","volume":"11","author":"Y Lu","year":"2022","unstructured":"Lu Y, Gao Q, Ren X, Li J, Yang D, Zhang Z, et al. Incidence and prevalence of 121 rare diseases in China: current status and challenges: 2022 revision. Intract Rare Dis Res. 2022;11(3):96\u2013104.","journal-title":"Intract Rare Dis Res"},{"key":"537_CR44","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1007\/978-90-481-9485-8_22","volume":"686","author":"B Gulbis","year":"2010","unstructured":"Gulbis B, Eleftheriou A, Angastiniotis M, Ball S, Surralles J, Castella M, et al. Epidemiology of rare anaemias in Europe. Adv Exp Med Biol. 2010;686:375\u201396.","journal-title":"Adv Exp Med Biol"},{"key":"537_CR45","doi-asserted-by":"publisher","first-page":"5","DOI":"10.20517\/rdodj.2023.39","volume":"3","author":"N Venugopal","year":"2024","unstructured":"Venugopal N, Naik G, Jayanna K, Mohapatra A, Sasinowski FJ, Kartha RV, et al. Review of methods for estimating the prevalence of rare diseases. Rare Dis Orphan Drugs J. 2024;3:5.","journal-title":"Rare Dis Orphan Drugs J"},{"key":"537_CR46","unstructured":"Global Burden of Disease Study 2022. (GBD 2022) Results [Internet]. Institute for Health Metrics and Evaluation (IHME). 2022. Available from: https:\/\/www.healthdata.org"},{"issue":"5","key":"537_CR47","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1046\/j.1365-2141.2003.04721.x","volume":"123","author":"JC Marsh","year":"2003","unstructured":"Marsh JC, Ball SE, Darbyshire P, Gordon-Smith EC, Keidan AJ, Martin A, et al. Guidelines for the diagnosis and management of acquired aplastic anaemia. Br J Haematol. 2003;123(5):782\u2013801.","journal-title":"Br J Haematol"},{"issue":"25","key":"537_CR48","doi-asserted-by":"publisher","first-page":"4985","DOI":"10.1182\/blood-2012-09-311381","volume":"121","author":"A Hill","year":"2013","unstructured":"Hill A, Kelly RJ, Hillmen P. Thrombosis in paroxysmal nocturnal hemoglobinuria. Blood. 2013;121(25):4985\u201396. quiz 5105.","journal-title":"Blood"},{"issue":"19","key":"537_CR49","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1056\/NEJM199511093331904","volume":"333","author":"P Hillmen","year":"1995","unstructured":"Hillmen P, Lewis SM, Bessler M, Luzzatto L, Dacie JV. Natural history of paroxysmal nocturnal hemoglobinuria. N Engl J Med. 1995;333(19):1253\u20138.","journal-title":"N Engl J Med"},{"issue":"9027","key":"537_CR50","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1016\/S0140-6736(95)12360-1","volume":"348","author":"G Socie","year":"1996","unstructured":"Socie G, Mary JY, de Gramont A, Rio B, Leporrier M, Rose C, et al. Paroxysmal nocturnal haemoglobinuria: long-term follow-up and prognostic factors. Lancet. 1996;348(9027):573\u20137.","journal-title":"Lancet"},{"issue":"25","key":"537_CR51","doi-asserted-by":"publisher","first-page":"6786","DOI":"10.1182\/blood-2011-02-333997","volume":"117","author":"RJ Kelly","year":"2011","unstructured":"Kelly RJ, Hill A, Arnold LM, Brooksbank GL, Richards SJ, Cullen M, et al. Long-term treatment with eculizumab in paroxysmal nocturnal hemoglobinuria: sustained efficacy and improved survival. Blood. 2011;117(25):6786\u201392.","journal-title":"Blood"},{"key":"537_CR52","doi-asserted-by":"publisher","DOI":"10.1186\/s13023-014-0173-x","volume":"9","author":"RM Leadley","year":"2014","unstructured":"Leadley RM, Lang S, Misso K, Bekkering T, Ross J, Akiyama T, et al. A systematic review of the prevalence of Morquio A syndrome: challenges for study reporting in rare diseases. Orphanet J Rare Dis. 2014;9:173.","journal-title":"Orphanet J Rare Dis"},{"key":"537_CR53","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1186\/s13023-021-01769-6","volume":"16","author":"A-L Walter","year":"2021","unstructured":"Walter A-L, Baty F, Rassouli F, Bilz S, Brutsche MH. Diagnostic precision and identification of rare diseases is dependent on distance of residence relative to tertiary medical facilities. Orphanet J Rare Dis. 2021;16:131.","journal-title":"Orphanet J Rare Dis"}],"container-title":["Journal of Epidemiology and Global Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s44197-026-00537-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-026-00537-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s44197-026-00537-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:34:36Z","timestamp":1785886476000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s44197-026-00537-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":53,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["537"],"URL":"https:\/\/doi.org\/10.1007\/s44197-026-00537-8","relation":{},"ISSN":["2210-6014"],"issn-type":[{"value":"2210-6014","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"16 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 March 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics Approval and Consent to Participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for Publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"OZ, JB, PF and JF are full-time employees and shareholders of Novartis Pharma AG. OB is an employee of Cognizant Technology Solutions, under contract to provide literature search-related services to Novartis Pharma AG. MH receives research funding from Sobi and has received support with congress travel from Alexion. RK reports consultancy, research funding, speaker fees, and\/or advisory board attendance for Alexion, Amgen, Florio, Novartis Pharma AG, Omeros, Otsuka, Sobi, and Roche.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"99"}}